Open- | Close- |
Vol / Avg.285.000 / 684.270K | Mkt Cap117.619M |
Day Range- - - | 52 Wk Range0.860 - 7.350 |
Generation Bio Stock (NASDAQ: GBIO) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.285.000 / 684.270K | Mkt Cap117.619M |
Day Range- - - | 52 Wk Range0.860 - 7.350 |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.500 | -0.430 | 0.0700 | ||||
REV | 1.090M | 2.146M | 1.056M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-10 | Wedbush | David Nierengarten | Maintains | OutperformOutperform | Lowers | 11.00 | 9.00 |
2023-10-23 | JMP Securities | Silvan Tuerkcan | Downgrades | Market OutperformMarket Perform | - | - | - |
2023-10-19 | TD Cowen | Yaron Werber | Downgrades | OutperformMarket Perform | - | - | - |
2023-08-16 | JP Morgan | Anupam Rama | Maintains | NeutralNeutral | Raises | 8.00 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
GBIO | Generation Bio | 4.09% | 117.6M |
OTLK | Outlook Therapeutics | 0.87% | 111.9M |
GALT | Galectin Therapeutics | -3.16% | 113.8M |
CARM | CARISMA Therapeutics | 3.17% | 104.9M |
BRNS | Barinthus Biotherapeutics | -1.64% | 115.3M |
You can purchase shares of Generation Bio (NASDAQ: GBIO) through any online brokerage.
Other companies in Generation Bio’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Galectin Therapeutics (NASDAQ:GALT), CARISMA Therapeutics (NASDAQ:CARM), Barinthus Biotherapeutics (NASDAQ:BRNS) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for Generation Bio (NASDAQ: GBIO) was reported by Wedbush on Friday, November 10, 2023. The analyst firm set a price target for 9.00 expecting GBIO to rise to within 12 months (a possible 405.62% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Generation Bio (NASDAQ: GBIO) is $1.78 last updated December 9, 2023 at 12:31 AM UTC.
There is no dividend information for Generation Bio.
Generation Bio’s Q4 earnings are confirmed for Thursday, February 22, 2024.
There is no upcoming split for Generation Bio.
Generation Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.